血清G蛋白偶联受体激酶2水平与脓毒症相关肝损伤发生的关系
SALI组GRK2显著高于非SALI组[808.78(766.70, 832.14)vs. 586.40(553.43, 614.19)ng/L,P<0.05]。多因素Logistic回归示GRK2升高(OR=1.024,95%CI 1.016-1.033,P<0.001)、乳酸升高(OR=1.674,95%CI 1.160-2.418,P=0.006)、高BMI(OR=1.243,95%CI 1.032-1.498,P=0.022)为SALI独立危险因素。GRK2识别SALI的AUC 0.940(95%CI 0.893-0.988),cut-off 692.52 ng/L时敏感度0.96、特异度0.89;
要点
- 脓毒症患者入ICU 24小时内血清GRK2≥692.52 ng/L时识别SALI的敏感度0.96、特异度0.89,AUC 0.940(95%CI 0.893-0.988)。
- GRK2升高是SALI独立危险因素:每升高1 ng/L,OR=1.024(95%CI 1.016-1.033,P<0.001),校正BMI、吸烟史、乳酸。
- 乳酸升高(OR=1.674,95%CI 1.160-2.418,P=0.006)与高BMI(OR=1.243,95%CI 1.032-1.498,P=0.022)同为SALI独立危险因素。
- GRK2联合乳酸识别SALI的AUC 0.946(95%CI 0.903-0.989),较单用GRK2的0.940提升有限。
- SALI组28天死亡率显著高于非SALI组(P<0.05),提示合并肝损伤的脓毒症患者预后更差。
适用人群与场景
- 原文未提及明确的纳入标准、排除标准及脓毒症诊断所用标准名称。
诊断标准与关键阈值
- 以入组时是否发生SALI分为SALI组与非SALI组,原文未给出SALI的具体诊断标准与界值。
- 血清GRK2识别SALI的最佳cut-off值为692.52 ng/L,该界值下敏感度0.96、特异度0.89。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- SALI组28天死亡率显著高于非SALI组(P<0.05),合并肝损伤的脓毒症患者需警惕不良预后。
- 原文未给出针对GRK2升高或SALI的具体抢救处理措施。
研究设计与关键结果
- 研究类型:前瞻性观察研究,单中心(扬州大学附属苏北人民医院重症医学科),样本量144例(SALI 62例、非SALI 82例)。
- SALI组血清GRK2显著高于非SALI组[808.78(766.70, 832.14)vs. 586.40(553.43, 614.19)ng/L,P<0.05]。
- SALI组BMI、吸烟史比例、28天死亡率、乳酸、ALT、AST、总胆红素、间接胆红素、直接胆红素、凝血酶原时间、INR均显著高于非SALI组(均P<0.05)。
- 多因素Logistic回归:GRK2升高OR=1.024(95%CI 1.016-1.033,P<0.001);乳酸升高OR=1.674(95%CI 1.160-2.418,P=0.006);高BMI OR=1.243(95%CI 1.032-1.498,P=0.022)。
- ROC:GRK2识别SALI的AUC 0.940(95%CI 0.893-0.988),cut-off 692.52 ng/L时敏感度0.96、特异度0.89;GRK2联合乳酸AUC 0.946(95%CI 0.903-0.989)。
证据类型、等级与局限
- 证据类型:单中心前瞻性观察研究;原文未给出证据等级或推荐强度。
对床旁实践的改变
- 对脓毒症患者可在入ICU 24小时内检测血清GRK2,结合cut-off 692.52 ng/L辅助识别SALI高风险患者。
- GRK2联合乳酸(AUC 0.946)较单用GRK2(AUC 0.940)提升有限,原文未给出联合方案的cut-off值。
- 该指标为单中心观察性研究结果,原文未提及外部验证,不能替代SALI的常规诊断标准。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the relationship between serum G protein-coupled receptor kinase 2 (GRK2) level and the occurrence of sepsis-associated liver injury (SALI).
METHODS: A prospective observational study was conducted. Patients with sepsis admitted to the department of intensive care medicine of Northern Jiangsu People's Hospital Affiliated to Yangzhou University from January to December 2024 were enrolled. Baseline data were collected. Peripheral venous blood samples were obtained within 24 hours to measure laboratory indicators and detect serum GRK2 level using enzyme linked immunosorbent assay (ELISA). Patients were divided into SALI and non-SALI groups based on whether SALI occurred at enrollment. Logistic regression analysis was used to identify independent risk factors for SALI, and the identify value of serum GRK2 for SALI was evaluated using receiver operator characteristic curve (ROC curve). Internal validation was performed via Bootstrap resampling with 1 000 repetitions.
RESULTS: A total of 144 patients with sepsis were finally enrolled, including 82 in the non-SALI group and 62 in the SALI group. The level of serum GRK2 was significantly higher in the SALI group than that in the non-SALI group [ng/L: 808.78 (766.70, 832.14) vs. 586.40 (553.43, 614.19), P<0.05]. Additionally, compared with the non-SALI group, the SALI group showed significantly higher body mass index (BMI), proportion of smoking history, 28-day mortality, lactate, alanine aminotransferase, aspartate aminotransferase, total bilirubin, indirect bilirubin, and direct bilirubin, prothrombin time and international normalized ratio (all P<0.05). The indicators with statistically significant differences in univariate Logistic regression analysis, such as BMI, smoking history, GRK2, and lactate, were included in the multivariate Logistic regression analysis. The results showed that, elevated GRK2 [odds ratio (OR)=1.024, 95% confidence interval (95%CI) was 1.016-1.033, P<0.001], elevated lactate (OR=1.674, 95%CI was 1.160-2.418, P=0.006), and high BMI (OR=1.243, 95%CI was 1.032-1.498, P=0.022) were independent risk factors for SALI. ROC curve analysis showed that the area under the curve (AUC) of GRK2 for identifying SALI was 0.940, with a 95%CI of 0.893-0.988; the sensitivity was 0.96 and the specificity was 0.89 when the optimal cut-off value of 692.52 ng/L. The AUC of GRK2 combined with lactate was 0.946, with a 95%CI of 0.903-0.989. After internal validation, the AUC of GRK2 for identifying SALI was 0.940, with a 95%CI of 0.893-0.988.
CONCLUSIONS: Elevated serum GRK2 was positively correlated with the occurrence of SALI and may serve as a potential biomarker for assisting in the diagnosis of SALI.
参考来源
- Shao J, Wang T, Zhou L, et al. [The relationship between serum G protein-coupled receptor kinase 2 level and the occurrence of sepsis-associated liver injury]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2026. PMID: 42693972. doi:10.3760/cma.j.cn121430-20260402-00158
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。